Virginia Retirement Systems ET AL Takes $242,000 Position in Express Scripts (ESRX)

Virginia Retirement Systems ET AL purchased a new stake in Express Scripts (NASDAQ:ESRX) during the first quarter, according to its most recent filing with the SEC. The firm purchased 3,500 shares of the company’s stock, valued at approximately $242,000.

Several other large investors have also recently made changes to their positions in the stock. Bank of New York Mellon Corp raised its position in shares of Express Scripts by 8.7% in the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock valued at $618,609,000 after acquiring an additional 666,754 shares during the period. Geode Capital Management LLC raised its position in shares of Express Scripts by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after acquiring an additional 32,548 shares during the period. Schwab Charles Investment Management Inc. raised its position in shares of Express Scripts by 4.0% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 3,847,820 shares of the company’s stock valued at $286,701,000 after acquiring an additional 147,293 shares during the period. Pzena Investment Management LLC raised its position in shares of Express Scripts by 2.6% in the 4th quarter. Pzena Investment Management LLC now owns 3,602,780 shares of the company’s stock valued at $268,911,000 after acquiring an additional 92,980 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Express Scripts by 31.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,450,844 shares of the company’s stock valued at $257,571,000 after acquiring an additional 835,464 shares during the period. Institutional investors and hedge funds own 85.82% of the company’s stock.

A number of analysts recently weighed in on ESRX shares. Maxim Group increased their price target on shares of Express Scripts from $87.00 to $101.00 in a research report on Wednesday, February 28th. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 price target on the stock in a research report on Wednesday, February 14th. BidaskClub cut Express Scripts from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 2nd. Jefferies Group set a $91.00 target price on Express Scripts and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Finally, ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Thursday, April 26th. Five investment analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and an average price target of $82.50.

In other news, insider Christine Houston sold 19,889 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Everett Neville sold 4,895 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.

Shares of Express Scripts opened at $75.65 on Monday, according to Marketbeat Ratings. The company has a market cap of $42.49 billion, a PE ratio of 10.01, a price-to-earnings-growth ratio of 0.95 and a beta of 0.98. Express Scripts has a twelve month low of $55.80 and a twelve month high of $85.07. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.69 and a quick ratio of 0.56.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share for the quarter, topping the consensus estimate of $1.76 by $0.01. The company had revenue of $24.77 billion during the quarter, compared to analysts’ expectations of $24.80 billion. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the business earned $1.33 EPS. sell-side analysts expect that Express Scripts will post 9.07 EPS for the current fiscal year.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply